Please use this identifier to cite or link to this item:
https://doi.org/10.1074/jbc.M112.388702
DC Field | Value | |
---|---|---|
dc.title | Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer | |
dc.contributor.author | Ramachandran, L. | |
dc.contributor.author | Manu, K.A. | |
dc.contributor.author | Shanmugam, M.K. | |
dc.contributor.author | Li, F. | |
dc.contributor.author | Siveen, K.S. | |
dc.contributor.author | Vali, S. | |
dc.contributor.author | Kapoor, S. | |
dc.contributor.author | Abbasi, T. | |
dc.contributor.author | Surana, R. | |
dc.contributor.author | Smoot, D.T. | |
dc.contributor.author | Ashktorab, H. | |
dc.contributor.author | Tan, P. | |
dc.contributor.author | Ahn, K.S. | |
dc.contributor.author | Yap, C.W. | |
dc.contributor.author | Kumar, A.P. | |
dc.contributor.author | Sethi, G. | |
dc.date.accessioned | 2014-05-19T02:52:57Z | |
dc.date.available | 2014-05-19T02:52:57Z | |
dc.date.issued | 2012-11-02 | |
dc.identifier.citation | Ramachandran, L., Manu, K.A., Shanmugam, M.K., Li, F., Siveen, K.S., Vali, S., Kapoor, S., Abbasi, T., Surana, R., Smoot, D.T., Ashktorab, H., Tan, P., Ahn, K.S., Yap, C.W., Kumar, A.P., Sethi, G. (2012-11-02). Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer. Journal of Biological Chemistry 287 (45) : 38028-38040. ScholarBank@NUS Repository. https://doi.org/10.1074/jbc.M112.388702 | |
dc.identifier.issn | 00219258 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/53005 | |
dc.description.abstract | Background: PPAR-γ, a nuclear transcription factor, plays a critical role in the development of gastric cancer (GC). Hence, novel agents that can modulate PPAR-γ cascade have a great potential for the treatment of GC. Results: Isorhamnetin (IH) modulates PPAR-γ pathway in GC. Conclusion: IH induces apoptosis through the activation of the PPAR-γ pathway. Significance: The study proposes a novel agent for GC treatment. © 2012 by The American Society for Biochemistry and Molecular Biology, Inc. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1074/jbc.M112.388702 | |
dc.source | Scopus | |
dc.type | Article | |
dc.contributor.department | CANCER SCIENCE INSTITUTE OF SINGAPORE | |
dc.contributor.department | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE | |
dc.contributor.department | PHARMACY | |
dc.contributor.department | PHARMACOLOGY | |
dc.description.doi | 10.1074/jbc.M112.388702 | |
dc.description.sourcetitle | Journal of Biological Chemistry | |
dc.description.volume | 287 | |
dc.description.issue | 45 | |
dc.description.page | 38028-38040 | |
dc.description.coden | JBCHA | |
dc.identifier.isiut | 000310642200037 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.